Neuroendocrine carcinoma of the jugular foramen

Ear, Nose and Throat Journal

Volumn 87, Issue 2, 2008, Pages 86-91

  Leonetti, John P ^a   Shirazi, Mobeen A ^a   Marzo, Sam ^a   Anderson, Douglas ^b  

^a Skull Base Surgery Center   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN; CISPLATIN; ETOPOSIDE; SYNAPTOPHYSIN; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; ATAXIA; CANCER SURGERY; CASE REPORT; CHEMOTHERAPY; CHONDROSARCOMA; CHORDOMA; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE; CRANIAL NERVE PARALYSIS; CYTOPATHOLOGY; DIET; DIFFERENTIAL DIAGNOSIS; FEMALE; GRANULE CELL; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUGULAR FORAMEN; JUGULAR FORAMEN CARCINOMA; JUGULAR FORAMEN TUMOR; MENINGIOMA; METASTASIS; MULTIPLE CYCLE TREATMENT; NEURILEMOMA; NEUROENDOCRINE SYSTEM; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PATHOLOGY; PERCEPTION DEAFNESS; POSTOPERATIVE COMPLICATION; TINNITUS; VERTIGO; VOCAL CORD; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CARCINOMA; INTENSITY MODULATED RADIATION THERAPY; JUGULAR VEIN; MIDDLE AGED; SKULL BASE TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATAXIA; CARCINOMA, NEUROENDOCRINE; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DIAGNOSIS, DIFFERENTIAL; ETOPOSIDE; FEMALE; HEADACHE; HEARING LOSS, SENSORINEURAL; HUMANS; JUGULAR VEINS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; SKULL BASE NEOPLASMS; TINNITUS; VERTIGO;

EID: 45549094034     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130808700209     Document Type: Article

References (15)

1. Ramina R, Maniglia JJ, Fernandes YB, et al. Jugular foramen tumors: diagnosis and treatment. Neurosurg Focus 2004; 17 ( 2 ): E5.
2. Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 2002; 15 ( 3 ): 264-278.
3. Browne JD. Management of nonepidermoid cancer of the larynx. Otolaryn Clin North Am 1997; 30 ( 2 ): 215-229.
4. Guild SR. The glomus jugulare, a nonchromaffin paraganglion, in man. Ann Otol Rhinol Laryngol 1953; 62 ( 4 ): 1045-71.
5. Cole JM, Beiler D. Long-term results of treatment for glomus jugulare and glomus vagale tumors with radiotherapy. Laryngoscope 1994; 104 ( 12 ): 1461-65.
6. Molony TB, Brackmann DE, Lo WW. Meningiomas of the jugular foramen. Otolaryngol Head Neck Surg 1992; 106 ( 2 ): 128-36.
7. Streitmann MJ, Sismanis A. Metastatic carcinoma of the temporal bone. Am J Otol 1996; 17 ( 5 ): 780-83.
8. Chung JH, Lee SS, Shim YS, et al. A study of moderately differentiated neuroendocrine carcinomas of the larynx and an examination of non-neoplastic larynx tissue for neuroendocrine cells. Laryngoscope 2004; 114 ( 7 ): 1264-70.
9. Veronese SM, Maisano C, Scibilia J. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer. Anticancer Res 1995; 15 ( 6B ): 2717-22.
10. Szyldergemajn SA, O'Connor J, Mendez G, et al. Neuroendocrine tumors of the gastroenteropancreatic system (NET-GEP) correlation between Ki-67 immunostaining, histological features and clinical behaviour. J Clin Oncol 2005; 23 ( June 1 Suppl ): 4192.
11. Martin B, Paesmans M, Mascaux C, et al. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. British J Cancer 2004; 91 ( 12 ): 2018-25.
12. Whitaker D, Dussek J. PET scanning in thymic neuroendocrine tumors. Chest 2004; 125 ( 6 ): 2368-69.
13. Vento JA, Solis V, Spencer RP, Karimeddini MK. Mastoid bone as a single site of metastasis of neuroendocrine tumor. Clin Nucl Med 2003; 28 ( 4 ): 345-46.
14. Barker JL Jr, Glisson BS, Garden AS, et al. Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Cancer 2003; 98 ( 11 ): 2322-28.
15. Yu YC, Miyazaki J, Shin T. Neuroendocrine cells in the cat laryngeal epithelium. Eur Arch Otorhinolaryngol 1996; 253 ( 4-5 ): 287-93.